Skip to main content
About Us
About Us

Company profile, service system, quality philosophy and technical capabilities.

View all
Global Certification
Global Certification

Market-access routes covering testing, certification, registration and technical documentation.

View all
News & Insights
News & Insights

Regulatory updates, standards interpretation and practical product-compliance guides.

View all
Contact Us
Contact Us

Tell us the product, destination market and planned project to begin a technical review.

View all
Architectural concept illustration of a modern testing institution

TESTING SERVICES

Professional Testing Services
Home > Testing Services > FDA Drug Establishment Registration and NDC Listing

FDA Drug Establishment Registration and NDC Listing

Establishment, labeler-code, NDC and SPL preparation coordinated with formula, intended use, package labeling and maintenance for products regulated as drugs in the United States.

SCS starts with actual use, active ingredients and labeling, then maps the manufacturer, labeler and package presentations. This is especially useful when a product's claims place it on a different pathway from ordinary cosmetics.

Establishment registration, labeler-code assignment and drug listing are separate steps. An NDC or directory entry does not indicate FDA approval and does not replace review of the marketing basis. Required drug establishments also need annual registration maintenance.

Architectural concept illustration of a modern testing institution

Service Details

Service typeTechnical Service

Delivery modeRegistration, submission and document support

Applicable productsHuman drugs including OTC products; manufacturers, repackagers, relabelers and relevant labelers

MarketsUnited States

Regulations and standards21 CFR Part 207; FDA registration/listing procedures and SPL rules; the applicable drug marketing pathway

Scope of serviceInitial drug/cosmetic use screening; establishment and labeler mapping; labeler-code/NDC information support; SPL preparation and update assistance

Required documentsBusiness/facility identities, existing identifiers, active/inactive ingredients, dosage form, administration route, strengths, packages, English labeling, SPL records and marketing-basis documents

Sample requirementsRegistration/listing preparation is document-based. Agree samples separately for any required quality or analytical work.

Lead timeThe schedule is confirmed after reviewing the requested work, sample readiness and any external review steps.

DeliverablesReviewed establishment/product records, SPL preparation/submission records, label comments and maintenance actions

Issuing partySubmissions and records follow the relevant regulator or scheme; SCS provides the agreed technical and application support.

FAQ · May an NDC be advertised as FDA approval?No. Check the drug's marketing basis and other applicable requirements separately from its identification and listing.

FAQ · Should a package-size change be reviewed?Yes. Check package coding, label images and SPL records against the version to be sold, then determine the necessary updates.

Project Steps and Delivery

Project stepsRequirements review → document and sample assessment → project confirmation → testing or submission → technical review → delivery

Project confirmationConfirm product models, applicable standards, samples and deliverables.

DeliveryProvide the agreed reports or technical documents following technical review.

QUALIFICATION DOCUMENTSQualification and accreditation documents

Qualifications apply only within the scope and validity stated in the published documents. They do not imply that every project is covered by the same accreditation.

View qualification documents
Project consultation
Tell Us About Your Product and Project

Describe your product, destination market and intended project so the technical team can review the requirements and discuss the next steps with you.